Hammond, B <br/><br/>
The pulmonary hypertension of sclerosing agents is prevented by cyclooxygenase inhibitors.  [electronic resource] 

 -  The American journal of the medical sciences  Sep 1985 
 - 98-101 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0002-9629 
<br/><br/><label>Standard No.: </label>10.1097/00000441-198509000-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Pressure--drug effects<br/>Cyclooxygenase Inhibitors<br/>Drug Combinations<br/>Female<br/>Hypertension, Pulmonary--etiology<br/>Ibuprofen--pharmacology<br/>Indomethacin--pharmacology<br/>Lung--drug effects<br/>Lymph--analysis<br/>Lymphatic Diseases--therapy<br/>Organ Size<br/>Pulmonary Wedge Pressure--drug effects<br/>Sclerosing Solutions--adverse effects<br/>Serum Albumin--analysis<br/>Sheep<br/>Sodium Morrhuate--pharmacology<br/>Sodium Tetradecyl Sulfate--pharmacology